SOURCE: Argenta Reimbursement Advisors

March 19, 2007 07:30 ET

Dr. Brent J. O'Connell, Payer Medical Director and Technology Assessment Veteran, Joins Argenta Reimbursement Advisors™ as Chief Medical Officer of Its Newly Formed Subsidiary, Argenta TEC


SEATTLE, WA and BOSTON, MA and MINNEAPOLIS, MN -- (MARKET WIRE) -- March 19, 2007 -- Argenta Reimbursement Advisors™ (Argenta), a leading national life science reimbursement consulting firm, announced today that Brent J. O'Connell, M.D., M.H.S.A., has joined its team as Chief Medical Officer of the Argenta subsidiary, Argenta TEC Advisors™ (Argenta TEC).

Argenta TEC is focused on guiding life science companies through the complexities of medical technology review and payer coverage. Under Dr. O'Connell's leadership, Argenta TEC extends Argenta's overall offerings with medical advisory panels, technology assessments, and clinical trial design. Argenta TEC facilitates the coverage process for medical technologies by providing insight into the payer review process, access to payer medical directors, and assistance with coverage challenges.

"Brent is one of the foremost payer experts in the country and a tremendous addition to Argenta's reimbursement advisory team," said Louise Guy, R.N., Managing Partner of Argenta Reimbursement Advisors. "Brent's extensive knowledge of and experience with both private and government (state and federal) health policy and technology assessment will significantly augment the strategic reimbursement counsel we provide to our clients throughout the medical technology lifecycle."

Dr. O'Connell recently retired after 15 years as Medical Director of Highmark® BlueCross BlueShield (BCBS), one of the largest BCBS plans in the country, where he oversaw the development of corporate medical policies. During his tenure at Highmark, Dr. O'Connell established systematic procedures for assessing new technologies and making coverage decisions. In addition to Dr. O'Connell's role at Highmark, he served as the Chair of the BlueCross BlueShield Association's (BCBSA) Medical Policy Panel for six years and was a member of the BCBSA Technology Evaluation Center's Medical Advisory Panel for four years. Until recently, Dr. O'Connell also served as a member of the Medicare Coverage Advisory Committee (MCAC), which focuses on promoting effective, state-of-the-art healthcare coverage for Medicare beneficiaries.

"I am very pleased to be joining an organization that approaches the reimbursement process for medical technologies in an integrated and comprehensive way," said O'Connell. "I look forward to utilizing my experience as a plan medical director with life science companies to develop and implement successful reimbursement strategies within this evidence-based and complex coverage environment."

About Argenta Reimbursement Advisors

Argenta Reimbursement Advisors, with offices in Seattle, Boston, and Minneapolis, provides strategically integrated reimbursement solutions to life science companies. Whether a product is in the early stages of development or is already on the market, Argenta's focus is to deliver actionable strategic reimbursement counsel in order to work in concert with achieving the client's business objectives. The Argenta team has the unique ability to leverage its expertise along the full continuum from strategy formation and coding and payment systems analysis to payer negotiations. This means that Argenta can be a single-source solution for addressing the unique reimbursement needs of companies in the medical device, pharmaceutical, and biotechnology industries. To learn more about Argenta Reimbursement Advisors, visit the Company's website at:

Contact Information

  • Argenta Reimbursement Advisors
    Media Contacts:

    Louise Guy, RN
    Managing Partner
    Phone: 508.699.6888

    Carla Monacelli
    Managing Partner
    Phone: 651.222.1260